[go: up one dir, main page]

PE20090292A1 - Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante - Google Patents

Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante

Info

Publication number
PE20090292A1
PE20090292A1 PE2008000866A PE2008000866A PE20090292A1 PE 20090292 A1 PE20090292 A1 PE 20090292A1 PE 2008000866 A PE2008000866 A PE 2008000866A PE 2008000866 A PE2008000866 A PE 2008000866A PE 20090292 A1 PE20090292 A1 PE 20090292A1
Authority
PE
Peru
Prior art keywords
agent
pharmaceutical composition
combination
composition including
inflammatory agent
Prior art date
Application number
PE2008000866A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Murillo Josefina Santos
Ochoa Victor Guillermo Alvarez
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090292(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of PE20090292A1 publication Critical patent/PE20090292A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a)UN AGENTE ANTICONVULSIVANTE, TAL COMO GABAPENTINA EN CANTIDAD DE 3mg A 300mg; b)UN AGENTE ANTIINFLAMATORIO NO ESTEROIDEO, TAL COMO MELOXICAM, EN CANTIDAD DE 0.1mg A 30mg. DICHA COMPOSICION ES ADMINISTRABLE POR VIA ORAL, EN FORMA DE CAPSULAS Y TABLETAS Y ES DE UTILIDAD EN EL TRATAMIENTO DE DOLOR NEUROPATICO
PE2008000866A 2007-05-21 2008-05-20 Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante PE20090292A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007006093A MX2007006093A (es) 2007-05-21 2007-05-21 Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.

Publications (1)

Publication Number Publication Date
PE20090292A1 true PE20090292A1 (es) 2009-04-04

Family

ID=40032120

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000866A PE20090292A1 (es) 2007-05-21 2008-05-20 Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante

Country Status (7)

Country Link
AR (1) AR066668A1 (es)
CL (1) CL2008001476A1 (es)
CO (1) CO6241103A2 (es)
MX (1) MX2007006093A (es)
PE (1) PE20090292A1 (es)
UY (1) UY31095A1 (es)
WO (1) WO2008143490A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1093366E (pt) * 1998-07-09 2005-02-28 Warner Lambert Co Composicao farmaceutica que contem analogos de gaba e um agente antiviral para o tratamento de herpes zoster

Also Published As

Publication number Publication date
MX2007006093A (es) 2009-02-25
CO6241103A2 (es) 2011-01-20
CL2008001476A1 (es) 2008-07-11
WO2008143490A1 (es) 2008-11-27
UY31095A1 (es) 2008-11-28
AR066668A1 (es) 2009-09-02

Similar Documents

Publication Publication Date Title
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
AR078417A1 (es) Composiciones de pelicula sublingual y bucal
ECSP088239A (es) Composición de liberación de fármaco sostenida
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
PE20120956A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
BRPI0909211B8 (pt) formulação oral em forma de comprimido de compostos de tetraciclina
MX2007000117A (es) Una composicion de combinacion.
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
AR062925A1 (es) Metodo para fabricar tabletas que contienen agentes farmacologicamente activos
ECSP099734A (es) Composición farmaceutica que comprende la combinación de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
PE20061314A1 (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
AR065917A1 (es) Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor
PA8789101A1 (es) Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble
PE20090292A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
PE20091030A1 (es) Composiciones farmaceuticas que comprenden la combinacion de un agente antiinflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa
UY26176A1 (es) Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas.
AR048958A1 (es) Medicamento en forma de pelicula para administracion por via oral, que contiene estriol
AR059081A1 (es) Composicion farmaceutica estable de carisoprodol y meloxicam
AR057413A1 (es) Polvo desintegrable oralmente que comprende cilostazol
AR062613A1 (es) Formulacion de compuestos organicos
GT200900275A (es) Composiciones farmacéuticas sinérgicas que comprenden la combinación de un inhibidor de la enzima 5 a-reductasa y un antagonista de los receptores 1 a-andrenérgicos.
PE20090316A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias
UY31856A (es) Nueva asociacion de ingredientes activos que contienen un farmaco antiflamatorio, no esteroideo y un derivado de colchicosido

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed